Becket

Becket is a biotechnology company focused on building a next-generation platform for the design and manufacture of complex medicines, specifically biologics. Founded by industry veterans from Ginkgo Bioworks, the company leverages advanced synthetic biology and automation to streamline the production of high-value therapeutic proteins. Becket's platform aims to address critical bottlenecks in biologics development, such as scalability and manufacturing costs, by integrating computational design with automated foundry operations. The company operates primarily as a platform-based entity, targeting the optimization of expression systems and manufacturing workflows for the pharmaceutical industry. By bridging the gap between discovery and commercial production, Becket seeks to accelerate the delivery of complex biological products to patients.